Tergase injection for reducing swelling after double knee replacement
Part of Bones, joints & muscles clinical trials.
This trial tests an injection called Tergase to see if it reduces swelling after double knee replacement surgery. If you're having both knees replaced, this could help you recover with less swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 85 years old.
- You must be scheduled to have both knees replaced (bilateral total knee arthroplasty) due to osteoarthritis.
- You must have significant knee pain (at least 5 out of 10) during daily activities.
- You must be in generally good health (classified as ASA I or II).
- You must not have inflammatory arthritis (like rheumatoid arthritis) or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single injection of a knee lubricant (hyaluronic acid and chondroitin) combined with a rehab program tailored for sports-active adults with knee arthritis. The goal is to reduce pain and improve your ability to return to sports without surgery.
This study tests whether a single steroid injection in the healthy knee (the one not being replaced) can reduce pain and improve recovery after total knee replacement. It may help people who have arthritis in both knees but are only having one replaced now.
This study tests a single injection into the knee joint to see if it relieves pain from knee osteoarthritis. It may help people who have tried other treatments without feeling better.
This trial tests whether one injection of hyaluronic acid, a substance that helps lubricate joints, can reduce knee pain and improve function in people with knee osteoarthritis. If you have knee pain and are looking for a non-surgical option, this study might be a good fit.
This study tests a procedure called transcatheter arterial micro-embolization (a targeted injection done through blood vessels) to lessen pain from knee osteoarthritis. It may help people who still have significant pain despite standard “non-surgical” treatments like therapy and joint injections.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
Hear when a new Postoperative Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.